ABVC
ABVC BIOPHARMA, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.00
+1.51%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 0.76x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 86.24x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.59x
- Price / sales
- -33.54x
- Price / cash flow
- -9.92x
Enterprise value
- Enterprise value
- $30.3M
- EV / sales
- -38.13x
- EV / EBITDA
- -3.92x
- EV / EBIT
- -4.15x
- Market cap
- $26.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026